These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35039141)

  • 1. [Comparative study in primary care of the stability of INR in patients treated with warfarin or fluindione for atrial fibrillation. The FLOWER study (FLuindione Or WarfarinE - Result INR)].
    Giron A; Lambert C; Berland M; Schmidt J; Poinas L; Charuel E; Ménini T; Pereira B; Vorilhon P
    Ann Cardiol Angeiol (Paris); 2022 Jun; 71(3):123-129. PubMed ID: 35039141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Warfarin Management and Outcomes in Patients with Nonvalvular Atrial Fibrillation Within an Integrated Health Care System.
    An J; Niu F; Zheng C; Rashid N; Mendes RA; Dills D; Vo L; Singh P; Bruno A; Lang DT; Le PT; Jazdzewski KP; Aranda G
    J Manag Care Spec Pharm; 2017 Jun; 23(6):700-712. PubMed ID: 28530526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Quality of Anticoagulation Therapy among Warfarin-Treated Patients with Atrial Fibrillation in a Primary Health Care Setting.
    Urbonas G; Valius L; Šakalytė G; Petniūnas K; Petniūnienė I
    Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30650565
    [No Abstract]   [Full Text] [Related]  

  • 4. Descriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: the international study of anticoagulation management (ISAM).
    Ansell J; Hollowell J; Pengo V; Martinez-Brotons F; Caro J; Drouet L
    J Thromb Thrombolysis; 2007 Apr; 23(2):83-91. PubMed ID: 17221328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of anticoagulant control and patient experience associated with long-term warfarin in Canadian patients with non-valvular atrial fibrillation: A multicentre, prospective study.
    Selby R; Kaus L; Sealey F; Koo M; Parpia S; Chan B; Seung SJ; Bradley C; Strauss R; Mittmann N
    PLoS One; 2023; 18(4):e0284425. PubMed ID: 37071625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Warfarin time in therapeutic range and its impact on healthcare resource utilization and costs among patients with nonvalvular atrial fibrillation.
    Deitelzweig S; Evans M; Hillson E; Trocio J; Bruno A; Tan W; Lingohr-Smith M; Singh P; Lin J
    Curr Med Res Opin; 2016; 32(1):87-94. PubMed ID: 26451675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation. A randomized trial (Fluindione, Fibrillation Auriculaire, Aspirin et Contraste Spontané; FFAACS).
    Lechat P; Lardoux H; Mallet A; Sanchez P; Derumeaux G; Lecompte T; Maillard L; Mas JL; Mentre F; Pousset F; Lacomblez L; Pisica G; Solbes-Latourette S; Raynaud P; Chaumet-Riffaud P;
    Cerebrovasc Dis; 2001; 12(3):245-52. PubMed ID: 11641591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time in therapeutic range and stability over time for warfarin users in clinical practice: a retrospective cohort study using linked routinely collected health data in Alberta, Canada.
    McAlister FA; Wiebe N; Hemmelgarn BR
    BMJ Open; 2018 Jan; 8(1):e016980. PubMed ID: 29382672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How well does the target INR level maintain in warfarin-treated patients with non-valvular atrial fibrillation?
    Kim JH; Song YB; Shin DH; Kim JS; Choi JO; On YK; Kim JS
    Yonsei Med J; 2009 Feb; 50(1):83-8. PubMed ID: 19259353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chinese stroke patients with atrial fibrillation used Robert's age-adjusted warfarin loading protocol obtained good INR results within therapeutic range.
    Luo W; Luo X; Chen S; Li J; Huang X; Rao Y; Xu W
    Sci Rep; 2023 Oct; 13(1):18230. PubMed ID: 37880296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial.
    Singer DE; Hellkamp AS; Piccini JP; Mahaffey KW; Lokhnygina Y; Pan G; Halperin JL; Becker RC; Breithardt G; Hankey GJ; Hacke W; Nessel CC; Patel MR; Califf RM; Fox KA;
    J Am Heart Assoc; 2013 Feb; 2(1):e000067. PubMed ID: 23525418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation.
    Yasaka M; Minematsu K; Yamaguchi T
    Intern Med; 2001 Dec; 40(12):1183-8. PubMed ID: 11813841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of warfarin management in primary care: Determining the stability of international normalized ratios using a nationally representative prospective cohort.
    Liu S; Singer A; McAlister FA; Peeler W; Heran BS; Drummond N; Manca DP; Allan GM; Korownyk C; Kolber MR; Greiver M; Garrison SR
    Can Fam Physician; 2019 Jun; 65(6):416-425. PubMed ID: 31189630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between time spent at extreme International Normalized Ratios and time in therapeutic range with bleeding and thrombosis in warfarin-treated patients.
    Barta AL; Nutescu EA; Thompson PA; Bussey HI; Gulseth MP
    Am J Health Syst Pharm; 2015 Jul; 72(14):1188-94. PubMed ID: 26150568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
    JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-Analysis Evaluating the Efficacy and Safety of Low-Intensity Warfarin for Patients >65 Years of Age With Non-Valvular Atrial Fibrillation.
    Kang F; Ma Y; Cai A; Cheng X; Liu P; Kuang J; Mai Z; Mai W
    Am J Cardiol; 2021 Mar; 142():74-82. PubMed ID: 33307015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International Normalized Ratio Variability: A Measure of Anticoagulation Quality or a Powerful Mortality Predictor.
    Vanerio G
    J Stroke Cerebrovasc Dis; 2015 Oct; 24(10):2223-8. PubMed ID: 26232891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of time in therapeutic range in switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulants in atrial fibrillation.
    Vinding NE; Bonde AN; Rørth R; Lamberts M; Olesen JB; Gislason GH; Torp-Pedersen C; Køber L; Fosbøl EL
    Europace; 2019 Apr; 21(4):572-580. PubMed ID: 30508073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
    Hirano T; Kaneko H; Mishina S; Wang F; Morita S
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a mobile electronic assistant to aid in fluindione prescription: the INRPlus cluster randomized trial.
    Imbert P; Pernod G; Jacquet JP; Bailly C; Laporte S; Lievre M;
    Thromb Res; 2014 May; 133(5):756-61. PubMed ID: 24582071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.